Available Technologies

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Find technologies available for licensing from UC Davis.

Real-Time Aortic Flow Meter and Syringe Pump for Partial-Aortic Occlusion

Researchers at the University of California, Davis have developed a device which utilizes blood pressure waveforms to estimate the real-time rate of aortic flow past an endovascular balloon.

Scalable Phased Array Standing Wave Architecture

Researchers at the University of California, Davis have developed a standing wave architecture for scalable and wideband millimeter wave and terahertz radiator and phased arrays.

Nanoporous Metal Foam Filters for Clean Air

Researchers at the University of California, Davis have developed nanoporous metal foams as universal pollutant arrestors.

Chemical Synthesis of Lipid Mediator 22-HDoHE and Structural Analogs

Researchers at the University of California, Davis have developed an efficient method to chemically synthesize the endogenous lipid mediator, 22-hydroxydocosahexaenoic acid (22-HDoHE) which can be applied to related natural mediators and analogs.

Rapid Screening and Identification of Antigenic Components in Tissues and Organs

Researchers at the University of California, Davis have developed an approach to rapidly screen and identify antigenic components in tissues and organs.

Butadiene Sulfone (BDS) as a Green Multi-Functional Telomerization Agent for Tunable Hydrophobic Nanocellulose

Researchers at the University of California, Davis have developed a green method green for the telomerization of cellulose using BDS as a multi-functional reagent, solvent and acid source.

Antibodies for Pseudomonas (P.) aeruginosa

Researchers at the University of California, Davis have developed recombinant antibodies (VHH or nanobodies) to diagnose and treat Pseudomonas (P.) aeruginosa infection.

Diagnosis and Treatment of Inflammatory Disease by Glycan Profiling of High Density Lipoprotein (HDL)

Researchers at the University of California, Davis have developed a method for diagnosing an individual patient’s risk of inflammatory disease based on glycan profiling of high density lipoprotein (HDL). The resulting profile is then used to recommend a treatment program of dietary, lifestyle, or pharmaceutical interventions (or combination thereof), to improve health and decrease the risk of inflammation-induced disease by modulating the patient’s HDL glycosylation pattern.